Table 1.
Participant characteristics of hormone levels and key psychopathology endpoints for women with anorexia nervosa (AN) versus atypical AN (AtypAN).
| Characteristic | AN (n=31) | AtypAN (n=22) | p | Hedges’ g |
|---|---|---|---|---|
| Estradiol (pg/mL)a | 55.9 ± 61.1 | 65.8 ± 48.8 | n/a | n/a |
| Ln-estradiola | 3.3 ± 1.4 | 3.7 ± 1.2 | 0.364 | -0.30 |
| Fasting oxytocin (pg/mL) | 1,018 ± 582 | 872 ± 308 | n/a | n/a |
| Ln-fasting oxytocin | 6.8 ± 0.5 | 6.7 ± 0.4 | 0.554 | 0.17 |
| EDE-Q Global Scoreb | 3.0 ± 1.6 | 3.5 ± 1.3 | 0.358 | -0.33 |
| BDI Total Scorec | 22.1 ± 10.8 | 23.4 ± 3.0 | 0.717 | -0.15 |
| STAI Trait Score | 53.7 ± 10.4 | 54.1 ± 13.1 | 0.906 | -0.03 |
| TAS-20 Difficulty Identifying Feelings Scored | 20.0 ± 6.5 | 20.8 ± 6.6 | 0.699 | -0.12 |
Mean ± SD. aData available for 36 participants (21 with AN and 15 with AtypAN), all of whom were off oral contraceptive pill medication. bData available for 35 participants (19 with AN and 16 with AtypAN). cData available for 36 participants (20 with AN and 16 with AtypAN). dData available for 50 participants (29 with AN and 21 with AtypAN). BDI, Beck Depression Inventory-IA; EDE-Q, Eating Disorder Examination Questionnaire; STAI, State-Trait Anxiety Inventory; TAS-20, Toronto Alexithymia Scale.